Hydroxychloroquine as Postexposure Prophylaxis to Prevent SARS-CoV-2 Infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial
Ann. Intern. Med 2020 Dec 08;[EPub Ahead of Print], RV Barnabas, ER Brown, A Bershteyn, HC Stankiewicz Karita, C Johnston, LE Thorpe, A Kottkamp, KM Neuzil, MK Laufer, M Deming, MK Paasche-Orlow, PJ Kissinger, A Luk, K Paolino, RJ Landovitz, R Hoffman, TT Schaafsma, ML Krows, KK Thomas, S Morrison, HS Haugen, L Kidoguchi, M Wener, AL Greninger, ML Huang, KR Jerome, A Wald, C Celum, HY Chu, JM BaetenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.